Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Pharmacogenetics-based coumarin therapy.
Brian F. Gage
Institute of Clinical and Translational Sciences (ICTS)
Division of General Medicine & Geriatrics
Research output
:
Contribution to journal
›
Review article
›
peer-review
64
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacogenetics-based coumarin therapy.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacogenetics
100%
Coumarin
100%
Single nucleotide Polymorphism
27%
CYP2C9
27%
Metabolism
18%
Therapeutic Agents
18%
VKORC1
18%
Hemorrhage Risk
9%
Genotype
9%
Common Variants
9%
Cytochrome P450 (CYP450)
9%
Vitamin K Epoxide Reductase
9%
Promoter Polymorphism
9%
Clinical Adverse Events
9%
Haplotype A
9%
Medicine and Dentistry
Pharmacogenetics
100%
Coumarin
100%
Single Nucleotide Polymorphism
30%
Haplotype
20%
CYP2C9
20%
Adverse Event
10%
Bleeding
10%
Clinician
10%
Promoter Region
10%
Cytochrome P450
10%
Coumarin Derivative
10%
CYP2C9*3
10%
Vitamin K Epoxide Reductase
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
Coumarin
100%
CYP2C9
20%
Adverse Event
10%
Bleeding
10%
Cytochrome P450
10%
Vitamin K Epoxide Reductase
10%
Coumarin Derivative
10%
CYP2C9*3
10%